Page

Home Page for StartUps 24-7

By Lilith Anderson  

Rating_icon_yellowRating_icon_yellowRating_icon_yellowRating_icon_yellowRating_icon_yellow

PublicCategorized as Public.

Not yet tagged

Triangle-table-group-3

What is CED's StartUps 24-7?

Wherever you are, whenever you need it, you can now access real-world, hands-on advice, how-to's and mentoring from experienced entrepreneurs, investors and expert business advisers.

StartUps 24-7 leverages CED's more than 150 annual forums, conferences, roundtables and workshops, as well as publications and specialized business development tools. StartUps 24-7 delivers anytime, anywhere access to dynamic content and unlocks a collaborative entrepreneurial support network that is second to none.

Coming Soon...

Podcast_image  Global Perspective - From the Southeast to the Far East
With increased globaliztion comes increased risk.  Stephen Wares, a vice president from Nair & Co, shares some little appreciated issues associated with doing business in Asia. Listen as he delves into employment law changes in the PRC, India's shift on cost plus arrangements, details concerning Japan & China's CHOP based banking systems, and avoiding software tax holdbacks in Korea.

Podcast_image   Service Provider vs. Service Partner




Podcast_imageNew Achieving Therapeutic Valuation for a Medtech Company
Listen as a panel of experts explore fundamental issues surrounding the product characteristics, intellectual property, regulatory, fund-raising and company-building that is required to yield a therapeutic-like valuation in a medtech company. Includes PowerPoint.  icon_protected.gif

Podcast_imageNew Building a World Class Company
Find out how to crack the billion dollar market cap level in Biotech and Therapeutics. This panel of entrepreneurs, of whom all are well on their way of doing just this, looks at how to build a team, board, investor syndicates and more. Includes PowerPoint.  icon_protected.gif

Podcast_imageNew An Invitation to a Partner Meeting
Have you ever wondered what happens in a Monday morning partner meeting at a venture capital firm? Intersouth Partners' Mitch Mumma provides a behind the scenes look at what goes on during these meetings, helping you better understand the investment process and the venture partner life cycle.
icon_protected.gif

Podcast_imageNew Define Your Total Addressable Market
The first step in creating your market strategy is to define your addressable market.  Listen as Keith Boswell of Burning Sky Ventures discusses the importance of defining your total addressable market (TAM).  Learn how to get a better understanding of the potential market for your produce.
Includes PowerPoint. icon_protected.gif

Podcast_imageNew Alternative Sources of Funding
While, the "right" funding varies from company to company and across industry verticals; Karen LaVert, CEO and co-founder of Durham-based Southeast TechInventures, Inc.outlines some of the options a company has to the raise capital needed to fund its business. Includes PowerPoint. icon_protected.gif

Podcast_imageNew When VC's Say No
Venture capital is not the only way to finance a growing business. Listen to a panel of experts as they discuss how entrepreneurs can act on alternative funding options, including bootstrapping, government grants, loans and other methods.
Includes PowerPoint.icon_protected.gif

Podcast_imageNew Commercialization Strategies for IP
Having a patent is great in theory. But, is it enough if you want to take your product or concept to the market? Intellectual property experts James Sheldon, an adjunct professor at the Fuqua School of Business at Duke University and Arles Taylor Jr., a partner at the law firm Jenkins, Wilson, Taylor & Hunt, P.A. discuss how to leverage your patent and successfully take your IP to the marketplace.
Includes PowerPoint.icon_protected.gif

Podcast_image  New How to Structure, Negotiate and Seal the Deal
Every story has at least two sides, so too do negotiations. Find out how an expert attorney and a venture capitalist approach structuring, negotiating and closing deals. Compare the viewpoint of Mark Mirkin, a partner in Williams Mullen's corporate finance and securities section with that of Rik Vandevenne, a principal at River Cities Capital Funds. Includes PowerPoint.icon_protected.gif

Podcast_imageNew Invest Globally: A Framework for Building Great Companies
Learn how to develop an early market strategy that will attract investors, help you manage risk, and uncover important factors to consider while developing a strategy to go global.

Recent Additions

Podcast_image Creating a Board of Directors and a Board of Advisors
Finding the right people to provide advice and direction for a company is difficult, regardless if your company is a Fortune 500 powerhouse or a garage start-up. Chris Lynch, from law firm Wyrick Robbins, Yates & Ponton, LLC. and Jesko von Windheim, CEO of Nextreme Thermal Solutions, Inc. break down the essentials of creating a board of directors and discuss how to manage your board without losing control of your company. Includes PowerPoint.icon_protected.gif

podcast_image.GIFEntrepreneurs: You've Got Questions, We've Got Answers 
Starting an entrepreneurial company can be a confusing process.  A panel of seasoned entrepreneurs answers audience questions about issues ranging from IP protection, to marketing and funding. Includes PowerPoint.  

If you still have questions after listening to this podcast, post them in the "Ask an Entrepreneur " forum and CED will find an expert to answer them for you.

Podcast_imageSurviving, Sustaining & Succeeding in the Pursuit of Innovation 
In this talk, Edward C. Saltzman, Founder and President of Defined Healthdiscusses why Big Pharma is, at least for the interim, becoming Much Smaller Pharma.  He explains why despite this dismal prognosis, the pending demise of Big Pharma will, in the future, be regarded as a positive development and how new business models are an urgent necessity if Pharma is ever to return to its golden years of innovation and growth -and if patients are going to have much needed new therapies. Includes PowerPoint. 

Report  Alnylam Pharmaceuticals: A Study of Biotechnology Innovation
In this discussion, Dr. John Maraganore shares the Alnylam story, attributing its success to "risk" and "innovation."  Maraganore points out that while the biotechnology industry faces challenges companies like Genentech, Amgen, Biogen Idec., Genzyme, and Chiron demonstrate innovative solutions to problems.  This is an area where pharmaceutical companies are struggling. Maraganore finishes his presentation with thoughts on how to improve innovation amongst biotechnology companies.

Report Venture Capital Trends in North Carolina
North Carolina companies raised more than $900 million in venture capital investments. This represents
a 72% increase over 2006 which compares favorably to a nationwide average increase of 16%. In
2007, North Carolina achieved its highest ever national ranking coming in as 7th based on the 2007
PricewaterhouseCoopers/National Venture Capital Association MoneyTree Survey.
Includes Report.

Podcast_imageDynamic Interdependence: Pharmaceuticals and Bio-Pharmaceuticals
Fredrick Frank of Lehman Brothers analyzes financial trends and issues in the biotechnology industry. Includes PowerPoint. 

Podcast_image Biotechnology Throughout North Carolina
From medicinal flora in the mountains to marine biotechnology on the coast, the breadth of natural resources make North Carolina a hot spot for biotechnology innovation.  Listen as six directors for the North Carolina Biotechnology Center discuss resources and assets associated with the center's 5 regional offices
. Includes PowerPoint.

Podcast_image  Medical Device Development
Medical technology icon, Richard Stack offers his thoughts on the best way to develop medical device, and specifically, implantable device, technologies and companies.  Stack uses Synecor, LLC as a foundation for this discussion. 

Podcast_image Globalization and Innovation: Myths and Reality
Deepak Advani, responsible for building the Lenovo corporate brand globally and generating demand for Lenovo's $14 billion global business dispels the myths and realities of global innovation.







Powered by Near-TimeTerms of Services | Privacy Policy | Security Policy |